Toggle light / dark theme

Never before have businesses been able to build billion-dollar valuations in so little time. Never before have incumbent enterprises been able to go out of business so quickly. Disruption is now commonplace, and augmented reality (AR) is emerging as yet another avenue to turn industries on their heads. But what direction will this new technology take?

AR overlays digital information on the physical world using a smartphone (think Pokémon Go) or a headset. In its simplest form, AR is simply a rectangular display floating in front of the eyes, à la Google Glass. More advanced forms will drop video game characters or useful information seamlessly onto physical objects, from homes to industrial warehouses.

While virtual reality is moving into a more commercial phase, AR is a little earlier in its development. But AR’s potential practical applications are significant. So, what’s in store for AR in the coming years?

Read more

Orginal press: http://www.prweb.com/releases/2017/02/prweb14062199.htm

Bioquark, Inc., (http://www.bioquark.com) a life sciences company focused on the development of novel biologics for complex regeneration and disease reversion, and SC21 Biotech, (http://www.sc21bio.tech), a biotechnology company focused on translational therapeutic applications of autologous stem cell therapy, have announced a collaboration to focus on novel cellular reprogramming and production approaches for CCR5 Delta32 homozygous cord blood stem cells, for long-term control of HIV via transplantation.

“We are very excited about this collaboration with SC21 Biotech,” said Ira S. Pastor, CEO, Bioquark Inc. “The natural synergy of our cellular reprogramming tools and SC21 Biotech’s translational cell therapy experience, will make for a transformational opportunity in this area of HIV disease control.”

HIV-1 infection afflicts more than 35 million people worldwide. For individuals who have access to antiretroviral therapy, these drugs can effectively suppress, but not cure, HIV-1 infection. The only documented case for an HIV/AIDS cure was a patient with HIV-1 and acute myeloid leukemia who received allogeneic hematopoietic cell transplantation from a graft that carried the HIV-resistant CCR5-Delta32 homozygous mutation. The patient has remained without any evidence of HIV infection for more than 8 years after discontinuation of antiretroviral drug therapy.

However, identifying immune matched adult CCR5- Delta32 homozygous donors for a given patients is not readily feasible in part because the prevalence is in only about 0.8%–1% of individuals of northern European descent and much less in other ethnic groups, as well as the fact that for such transplants with adult cells there needs to be a very close HLA match between donor and patient.

In contrast, cord blood that is CCR5- Delta32 homozygous provides a major advantage in that much less stringent HLA matching is required between donor and patient. However, a technological method to cost effectively and industrially scale the production of such cells has been missing.

“We look forward to working closely with Bioquark Inc. on this exciting initiative,” said Mr. Paul Collier, Managing Director of SC21 Biotech. “The ability to apply Bioquark’s cellular reprogramming tools in order to produce industrial quantities of such precious cell lines will offer a much greater global penetration of this important therapeutic modality for HIV.”

“Bioquark has spent several years studying the evolutionarily perfected ability of bioactive moieties found in ooplasms to turn back biological time and re-set cellular regulatory state” said Dr. Sergei Paylian, Founder, CSO, and President, Bioquark Inc. “This unique initiative is one more step in our broad translation of such natural capabilities to control the progression of human diseases.”

About Bioquark, Inc.

Bioquark Inc. is focused on the development of natural biologic based products, services, and technologies, with the goal of curing a wide range of diseases, as well as effecting complex regeneration. Bioquark is developing both biological pharmaceutical candidates, as well as products for the global consumer health and wellness market segments.

About SC21 Biotech

SC21 Biotech is a novel a biotechnology company focused on translational therapeutic applications, as well as expedited, experimental access for “no option” patients, to a novel range of regenerative and reparative biomedical products and services, with the goal of reducing human degeneration, suffering, and death.

My niece shared this with me; and the 1st thing of course that came to mind was VR/ AR funerals/ ceremonials as so many including myself cannot always be there doesn’t mean we could not engage/ participate in an event like a funneral or wedding. Maybe marriage via VR is a business just like a funeral via VR could be.


MEMPHIS, Tenn. (localmemphis.com) — A funeral home off Lamar Avenue is offering a different service from its competitors. You can drive up, say your final goodbyes to your loved ones, and you don’t even have to get out the car.

Ryan Bernard, owner of R. Bernard funeral home, says he got the idea from a funeral home in California. His main goal is to make it more convenient for families who are already dealing with losing a loved one.

Bernard wants his funeral home to stand out from the rest, so his family business is offering drive-thru services.

Read more

Hmmmm.


A private space company is suing the Defense Advanced Research Projects Agency (DARPA) for allegedly taking an idea and giving it to a foreign-owned competitor.

Orbital ATK accused DARPA, which develops military technology, of giving its business plan to repair satellites to Space Systems Loral (SSL), a company-based in California but registered as foreign-owned. Orbital ATK says handing business plans to SSL violates U.S. policy.

DARPA entered into a commercial partnership with Space Systems Loral (SSL) to take advantage of its Robotic Servicing of Geosynchronous Satellites (RSGS) program to capture, re-position, and repair satellites in orbit. DARPA plans to buy future RSGS services from SSL, despite it being a Bermuda-based company.

Read more

Sharing more research conducted on Quantum Bio’s Brain to Brain communications. For all my hardware/ device friends exploring their own futures in a QC world. This was resurfaced in Jan 2017; the report itself is still relevant. Quantum Bio truly will change our device markets, IoT, and medicine/ healthcare drastically. This will be where we truly see tech and bio as one.

Want to see real convergence of tech and bio meaning no more need for smart devices, improved immunology in humans to counteract proactively disease and illness, accelerate heal times from injuries, reverse aging, etc. then you need to definitely engage Quantum bio in your work and discoveries as many have seen its potential and making changes leveraging this technology.


What you do on the Internet is nobody’s business but yours. At ProxySite.com, we stand between your web use and anyone who tries to sneak a peek at it. Instead of connecting directly to a website, let us connect to the website and send it back to you, and no one will know where you’ve been. Big Brother (or other, less ominous snoops) won’t be able to look over your shoulder and spy on you to see what you’re reading, watching or saying.

Read more

I actually had a person recently state quantum was a fad; boy were they ever wrong.


During the next ten years, quantum technologies will become part of and revolutionize our everyday lives in the form of computers, sensors, encryption, and much more—and in a way that can be difficult for us to comprehend.

Businesses will also boost both their research and development activities in this area.

“As from 2018, EU’s future flagship project, which is backed by EUR 1 billion, will focus on quantum technology, and several European countries are investing massively in the area. Innovation Fund Denmark has contributed DKK 80 million, and over the next couple of years, more funds are likely to be allocated to quantum research,” explains Ulrik Lund Andersen, Professor at DTU Physics.

Read more

Since the past 4–5 years, we have seen a change in the shopping behavior of users, both online as well as offline. It has resulted from user’s reviews and recommendations about the products ranging from fashion to home to technology, all thanks to social websites like Facebook, Pinterest, Instagram and many other global as well as regional social sites. Social commerce is a term, coined by Yahoo in 2005, as a set of online shopping tools that take into account the user liking patterns, sharing reviews, information and advices on products, as per their usages, thus affecting the sales of those products.

There are two types of social commerce strategies — one is offsite where the e-retailer brings in the social angle from external social platforms, separate from their own websites, thus enhancing the sales and second is onsite social commerce platform where the website/platform uses its own channel to enhance sales based on content, context, and reviews etc. AI and ML Tech comes into play after these reviews and recommendations have been provided by the users and then placing the same in front of potential buyers for better decision making.

Artificial and machine learning technologies have been used by giants like Google, Microsoft, Facebook, and Apple for more than a decade to enhance their platforms for better user experience which can now be seen to be mandatory adaptation for most of the internet based businesses, not only as it shows better ROI, but also open countless doors for future digital opportunities.

Read more

While the USA has been extremely concerned about losing jobs (particularly manufacturing jobs to China), China performed a survey of businesses in the American Chamber of Commerce in Beijing and found that 25% had moved or were planning to move their businesses out of China. Half were going to other Asian countries and 40% to America, Canada or Mexico.

China’s worker wages are rising about 7–8% each year and they have a shrinking working age population as the people age.

China is making big moves in automation and large scale deployment of robotics. In 2014, President Xi Jinping talked about a robotics revolution. China has been the number one buyer of industrial robots since 2013. However, China lags other nations in terms of robots per worker.

Read more

Today, sewing relies on the low-tech power of human hands, but soon that may not be the case. Human workers are still needed for the final steps of making clothes, in order to align fabrics and correctly feed them into sewing machines. If robots could do that instead, shock waves of change would surely ripple through global supply chains and disrupt the lives of millions of low-wage earners in the developing world.

For better or worse, plenty of technologists, researchers, and companies are working on the challenge—but so far, getting robots to navigate the imprecisions of flimsy textile materials that easily bend has proven elusive.

One promising solution, though, has come from an unlikely place: the sleepless brain of Jonathan Zornow, a young freelance web developer with no previous background in robotics, manufacturing, or the apparel business. His project, Sewbo, recently demonstrated the world’s first robotically sewn garment, and the inspiration came while watching a late-night Science Channel show called How It’s Made.

Read more